Gene: APOBEC2
Official Full Name: apolipoprotein B mRNA editing enzyme catalytic subunit 2provided by HGNC
Gene Summary: Enables cytidine deaminase activity and identical protein binding activity. Involved in positive regulation of gene expression via chromosomal CpG island demethylation. Acts upstream of or within cytidine to uridine editing. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA11269 | APOBEC2 Knockout cell line (AC16) | Human | APOBEC2 | 1:3-1:4 | negative | Online Inquiry |
| KOA26715 | APOBEC2 Knockout cell line (BEAS-2B) | Human | APOBEC2 | 1:3~1:4 | negative | Online Inquiry |
| KOA42152 | APOBEC2 Knockout cell line (U-2932) | Human | APOBEC2 | 1:2-1:4 | negative | Online Inquiry |
| KOA57531 | APOBEC2 Knockout cell line (TPC-1) | Human | APOBEC2 | 1:5-1:8 | negative | Online Inquiry |
| KOA72959 | APOBEC2 Knockout cell line (NCM460) | Human | APOBEC2 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.